BOLT vs DAL · rev $7.7M vs P/E 12, rev $61.64B
Bolt Biotherapeutics (BOLT) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
BOLT currently screens at market cap $11.3M. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the BOLT and DAL stock pages for the full models.
Not investment advice.